New Haven, CT, United States of America

Steven D Podos

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Achillion Pharmaceuticals, Inc., Other. Active years: 1984-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven D Podos. Retrieved from https://idiyas.com/inventor/steven-d-podos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Tenafly, NJ (US) (1984)
  • New Haven, CT (US) (2024)

Company Filing History:


Years Active: 1984-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Steven D Podos

Introduction

Steven D Podos is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of complement-mediated disorders. With a total of 3 patents to his name, Podos has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

One of his latest patents focuses on targeted dosing for the treatment of complement-mediated disorders. The dosages and methods described provide desirable pharmacokinetic (PK) and pharmacodynamics (PD) characteristics that inhibit alternative pathway complement activity. Specifically, the patent outlines that at least 85% or more inhibition of AP activity in vivo can be achieved at dosages ranging from about 120 mg to 200 mg BID, which provides a plasma level of at least about 65 ng/ml. This level is crucial for reducing the risk of complement breakthrough. Additionally, the dosage form offers a significantly low C, providing an extra safety margin and better dosing flexibility.

Another significant patent by Podos involves therapeutic regimens for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). This patent provides methods for treating a subject with PNH by administering a therapeutically effective amount of complement component C5 (C5) inhibitor, complement component C3 (C3) inhibitor, or complement factor B (CFB) inhibitor. This is combined with a therapeutically effective amount of small molecule complement factor D (CFD) inhibitor, or a pharmaceutically acceptable salt thereof.

Career Highlights

Throughout his career, Steven D Podos has worked with various companies, including Achillion Pharmaceuticals, Inc. His work has significantly impacted the development of treatments for complex medical conditions.

Collaborations

Podos has collaborated with notable colleagues such as Mingjun Huang and Thomas Mittag. These collaborations have likely contributed to the innovative approaches he has taken in his research and patent applications.

Conclusion

Steven D Podos is a distinguished inventor whose work in pharmacology has led to important advancements in the treatment of complement-mediated disorders. His patents reflect a deep understanding of the complexities of medical treatment and a commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…